GALECTIN THERAPEUTICS INC — Director's Dealing 2014

Nov 19, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2014-11-18

Reporting Person: Prelack Steven (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-18	Common Stock	D	84283	—	Disposed	2936	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-11-18	Stock option (right to buy)	$7.08	A	6168	Acquired	2021-06-28	Common stock (6168)	Direct
2014-11-18	Stock option (right to buy)	$3.59	A	6269	Acquired	2023-03-28	Common stock (6269)	Direct

Footnotes

F1: This Form 4 is being filed to report the rescission of certain of the Reporting Person's previous stock option exercises from January 31, 2014.

F2: The options are fully vested.

F3: The options vest quarterly in eight equal installments beginning on May 12, 2013.